Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN396057 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-WAP Four-Disulfide Core Domain 2 (WFDC2) (AA 31-125) antibody
- Antibody type
- Monoclonal
- Description
- This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 31-125
- Isotype
- IgG
- Antibody clone number
- 3F9
- Vial size
- 100 μg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms.
Voxelwise genome-wide association study (vGWAS).
Human epididymis protein 4 is a biomarker for transitional cell carcinoma in the urinary system.
The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass.
HE4 as a biomarker for ovarian and endometrial cancer management.
Hellstrom I, Heagerty PJ, Swisher EM, Liu P, Jaffar J, Agnew K, Hellstrom KE
Cancer letters 2010 Oct 1;296(1):43-8
Cancer letters 2010 Oct 1;296(1):43-8
Voxelwise genome-wide association study (vGWAS).
Stein JL, Hua X, Lee S, Ho AJ, Leow AD, Toga AW, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Dechairo BM, Potkin SG, Weiner MW, Thompson P, Alzheimer's Disease Neuroimaging Initiative.
NeuroImage 2010 Nov 15;53(3):1160-74
NeuroImage 2010 Nov 15;53(3):1160-74
Human epididymis protein 4 is a biomarker for transitional cell carcinoma in the urinary system.
Xi Z, LinLin M, Ye T
Journal of clinical laboratory analysis 2009;23(6):357-61
Journal of clinical laboratory analysis 2009;23(6):357-61
The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass.
Montagnana M, Lippi G, Ruzzenente O, Bresciani V, Danese E, Scevarolli S, Salvagno GL, Giudici S, Franchi M, Guidi GC
Journal of clinical laboratory analysis 2009;23(5):331-5
Journal of clinical laboratory analysis 2009;23(5):331-5
HE4 as a biomarker for ovarian and endometrial cancer management.
Li J, Dowdy S, Tipton T, Podratz K, Lu WG, Xie X, Jiang SW
Expert review of molecular diagnostics 2009 Sep;9(6):555-66
Expert review of molecular diagnostics 2009 Sep;9(6):555-66
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ELISA
